Akero Therapeutics, Inc.·4

Jul 14, 4:09 PM ET

Judy Chou 4

4 · Akero Therapeutics, Inc. · Filed Jul 14, 2021

Insider Transaction Report

Form 4
Period: 2021-07-12
Judy Chou
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-1226,00026,000 total
    Exercise: $24.87Exp: 2031-07-12Common Stock (26,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 36 equal monthly installments, commencing on July 12, 2021.

Documents

1 file
  • 4
    tm2122186-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT